217 related articles for article (PubMed ID: 8706591)
1. The 4S study. Implications for prescribing.
van Boven AJ; Brügemann J; de Graeff PA; May JF; Crijns HJ
Drugs; 1996 Apr; 51(4):507-14. PubMed ID: 8706591
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).
Pyŏrälä K; Pedersen TR; Kjekshus J; Faergeman O; Olsson AG; Thorgeirsson G
Diabetes Care; 1997 Apr; 20(4):614-20. PubMed ID: 9096989
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
Plans-Rubió P
Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
[TBL] [Abstract][Full Text] [Related]
4. Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal.
Pedersen TR; Tobert JA
Drug Saf; 1996 Jan; 14(1):11-24. PubMed ID: 8713485
[TBL] [Abstract][Full Text] [Related]
5. [The Scandinavian Simvastatin Survival Study: the clinical consequences].
Larsen ML
Rev Esp Cardiol; 1995; 48 Suppl 5():39-42. PubMed ID: 7494939
[TBL] [Abstract][Full Text] [Related]
6. Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).
Kjekshus J; Pedersen TR
Am J Cardiol; 1995 Sep; 76(9):64C-68C. PubMed ID: 7572690
[TBL] [Abstract][Full Text] [Related]
7. The 4S study: a critical review.
Pauciullo P
Pharmacol Res; 1997 Mar; 35(3):165-6. PubMed ID: 9229401
[No Abstract] [Full Text] [Related]
8. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
Hsu I; Spinler SA; Johnson NE
Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
French JK; White HD; Greaves SC
N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.
Johannesson M; Jönsson B; Kjekshus J; Olsson AG; Pedersen TR; Wedel H
N Engl J Med; 1997 Jan; 336(5):332-6. PubMed ID: 9011785
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a model to project the long-term benefit and cost of alternative lipid-lowering strategies in patients with hypercholesterolaemia.
Cook JR; Yin D; Alemao E; Drummond M
Pharmacoeconomics; 2004; 22 Suppl 3():37-48. PubMed ID: 15669152
[TBL] [Abstract][Full Text] [Related]
12. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A
Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
[TBL] [Abstract][Full Text] [Related]
14. Results of recent large cholesterol-lowering trials and implications for clinical management.
Gotto AM
Am J Cardiol; 1997 Jun; 79(12):1663-6. PubMed ID: 9202359
[TBL] [Abstract][Full Text] [Related]
15. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S).
Lancet; 1995 May; 345(8960):1274-5. PubMed ID: 7746058
[TBL] [Abstract][Full Text] [Related]
16. Management of the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study after the Scandinavian Simvastatin Survival Study (4S).
Tonkin AM
Am J Cardiol; 1995 Sep; 76(9):107C-112C. PubMed ID: 7572678
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin and simvastatin prevention studies.
Jones PH
Am J Cardiol; 1990 Sep; 66(8):39B-43B. PubMed ID: 2206035
[TBL] [Abstract][Full Text] [Related]
18. [Current developments in prevention of coronary heart disease].
Windler E
Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967
[TBL] [Abstract][Full Text] [Related]
19. The 4S study: a critical review.
Crepaldi G
Pharmacol Res; 1997 Mar; 35(3):163. PubMed ID: 9229400
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S).
Jönsson B; Johannesson M; Kjekshus J; Olsson AG; Pedersen TR; Wedel H
Eur Heart J; 1996 Jul; 17(7):1001-7. PubMed ID: 8809516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
